EUVIMEDEUVIMED entdecken
Crossref

Role for MRI in Secondary Screening for Placenta Accreta

Edward Golob iD, Kashif Burney iD, Tamal Datta, Sally Lewis, Jazmin Gajadhar, Ramesh Ganapathy iD

British Journal of Hospital Medicine · 2025

DOI: 10.12968/hmed.2024.0528 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Hospital Medicine, 2025. Verfasst von Edward Golob und 5 weiteren Autor:innen. Beteiligte Einrichtung: Fetal Medicine, Epsom and St. Helier University Hospitals NHS Trust, London, UK. Hauptthemen laut MEDLINE: Placenta Accreta, Magnetic Resonance Imaging. Die Arbeit nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims/Background Rates of both placenta praevia and placenta accreta spectrum (PAS) are rising. There is significant morbidity associated with PAS and antenatal detection reduces morbidity at delivery. In the UK there is a move to centralise care of these cases in dedicated units. Incidental diagnosis is more common, in the absence of a regular screening program. In non-specialist hospitals, there is a need to consider adjunct confirmatory diagnostics prior to referral to specialist centres. This is important to ensure capacity management in specialist centres. Ultrasound (US) and Magnetic Resonance Imaging (MRI) have both been used to diagnose PAS with high levels of accuracy with experienced operators. The role of MRI as an adjunct with US has not been clearly defined but is often requested.

Methods

A retrospective analysis of all cases referred for MRI as a secondary modality after US to evaluate possible PAS. A total of 41 cases had MRI performed over 13 years with a trend of increasing demand over time.

Results

The series identified eleven cases of PAS. MRI demonstrated a high level of accuracy, similar to published literature (sensitivity 81.8%, Specificity 86.6%) and correctly reclassified 2 cases as PAS, which were considered normal on US. There were 2 cases of PAS which were missed by both US and MRI.

Conclusion

This series demonstrates increasing demand in our trust for MRI over the period of the study. The addition of MRI as a second test improved accuracy compared to ultrasound alone. MRI has a role in secondary screening for PAS in non-specialist units.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Placenta AccretaMagnetic Resonance ImagingHumansFemalePregnancyRetrospective StudiesAdultSensitivity and SpecificityUltrasonography, Prenatal

Stichwörter der Autor:innen

Magnetic Resonance Imagingcolor doppler ultrasonographyplacenta accretapostpartum hemorrhage

Autor:innen und Institutionen

  • Fetal Medicine, Epsom and St. Helier University Hospitals NHS Trust, London, UK.
  • Radiology, Epsom and St. Helier University Hospitals NHS Trust, London, UK.

ORCID-Profile: Edward Golob, Kashif Burney, Ramesh Ganapathy

Zitieren

APA

Golob, E., Burney, K., Datta, T., Lewis, S., Gajadhar, J., & Ganapathy, R. (2025). Role for MRI in Secondary Screening for Placenta Accreta. British Journal of Hospital Medicine. https://doi.org/10.12968/hmed.2024.0528

Vancouver

Golob E, Burney K, Datta T, Lewis S, Gajadhar J, Ganapathy R. Role for MRI in Secondary Screening for Placenta Accreta. British Journal of Hospital Medicine. 2025. doi:10.12968/hmed.2024.0528

BibTeX
@article{Golob2025,
  author = {Golob, Edward and Burney, Kashif and Datta, Tamal and Lewis, Sally and Gajadhar, Jazmin and Ganapathy, Ramesh},
  title = {Role for MRI in Secondary Screening for Placenta Accreta},
  journal = {British Journal of Hospital Medicine},
  year = {2025},
  doi = {10.12968/hmed.2024.0528}
}
Kostenlos starten →